HAVANT, United Kingdom, Jan. 6 /PRNewswire-FirstCall/ -- Xyratex Ltd (Nasdaq: XRTX), a leading provider of enterprise class data storage subsystems and storage process technology, today announced preliminary results for the fourth quarter and fiscal year ended November 30, 2008.


    Based upon preliminary, unaudited information, Xyratex Ltd expects:

    --  Revenues for the fourth quarter to be $285.4 million, an increase of
        15.1% compared to revenues of $248 million for the same period last
        year. Revenues for the full year to be $1,049.7 million, an increase
        of 12.7%, compared to revenues of $931.6 million for fiscal year 2007.
    --  A fourth quarter GAAP net loss of $63.2 million, or $2.17 per diluted
        share compared to GAAP net income of $11.7 million in the same period
        last year. A GAAP net loss for fiscal year 2008 of $55.4 million or
        $1.90 per diluted share compared to a GAAP net income of $28.1 million
        for fiscal year 2007.
    --  A fourth quarter non-GAAP net loss of $6.3 million, or $0.22 per
        diluted share compared to non-GAAP net income of $13.1 million, in the
        same quarter a year ago. A non-GAAP net income for fiscal year 2008 of
        $9.5 million, or a diluted earnings per share of $0.32 compared to
        non-GAAP net income of $37.5 million, or $1.26 per diluted share, for
        fiscal year 2007(1).
    --  Gross profit margin in the fourth quarter of 9.8%, compared to 18.5%
        in the same period last year and 17.6% in the prior quarter.

Included in both the 2008 fourth quarter and full year preliminary GAAP results, but excluded from the non-GAAP results are the following significant charges:



    --  A non-cash impairment of Goodwill of $34.3 million. The Company has
        considered the value of Goodwill as required under FAS142 and
        primarily as a result of the recent share price decline, associated
        with the current macroeconomic environment, it has concluded that a
        full impairment should be taken against the value of Goodwill.
    --  A non-cash valuation allowance against the deferred tax asset of $20.6
        million. This valuation allowance relates primarily to UK tax losses
        which are not expected to be utilized as a result of the current
        economic situation, certain tax concessions in the UK and the tax
        structure of the overall Xyratex Ltd group. This valuation allowance
        does not indicate in itself that the overall Xyratex Ltd group will
        not be profitable in future fiscal periods.

Included in both the 2008 fourth quarter and full year GAAP and non-GAAP preliminary results are the following significant charges:



    --  An additional Inventory provision of approximately $5 million. This
        provision primarily relates to the Networked Storage Solutions (NSS)
        RAID products which have seen a material decline in demand associated
        with the current global economic situation.
    --  A specific provision of $9.5 million representing inventory and future
        vendor claims. This provision is associated with a specific NSS
        customer's  product forecast which currently indicates a transition to
        an updated version sooner than originally planned, giving rise to an
        exposure on long lead time components. The value of this exposure is
        dependent upon product demand and final timing of this proposed
        transition.

        As at the date of this release the Company is still assessing the
        extent of this specific provision and opportunities to mitigate the
        overall exposure. The outcome of this exercise is not expected to be
        finalized until the end of January at the earliest and hence the
        Company has provided at this point what it believes will be its
        maximum probable exposure of $9.5 million. This is the one area where
        the Company recognizes a material level of uncertainty and has
        resulted in all financial results in this press release being
        described as preliminary. Adjustment to the provision may be required
        once the analysis is completed, and any such adjustment will be
        reflected in a subsequent filing giving final 2008 fourth quarter and
        full year results.

Revenues from sales of our NSS products are expected to be $222.3 million in the fourth quarter as compared to $187.2 million in the same quarter a year ago, an increase of 18.7%. Gross profit margin in the NSS business is expected to be 5.0% as compared to 15.0% a year ago, having been reduced by 6.5% as a result of the provisions described in the preceding section. Revenues from sales of our Storage Infrastructure (SI) products are expected to be $63.1 million as compared to $60.8 million in the same quarter a year ago, an increase of 3.9%. Gross profit margin in the Storage Infrastructure business is expected to be 27.3% as compared to 29.7% a year ago.

"The worsening macroeconomic environment and the pace at which business conditions have changed have resulted in some significant one time non-cash and cash charges in the fourth quarter as detailed in this press release. I do however remain cautiously optimistic with regard to our long-term opportunities and competitive position. I fundamentally believe that we have the right combination of technology and financial strength to be successful in the markets we serve. And while we are not immune from constrained capital expenditure by the Hard Drive Industry, I believe our competitive differentiation and business fundamentals in both of our businesses remain strong," said Steve Barber, CEO of Xyratex. "We will remain focused on executing in all areas of our business as we navigate through the current challenging macroeconomic environment."

Business Outlook

Given the reduced visibility caused by the recent changes in the macroeconomic environment, Xyratex Ltd will not be providing formal financial guidance for the first quarter of fiscal year 2009.

Conference Call/Webcast Information

Xyratex quarterly results conference call will be broadcast live via the internet at http://www.xyratex.com/investors on Tuesday, January 6, 2009 at 2:00 p.m. Pacific Time/5:00 p.m. Eastern Time. You can also access the conference call by dialing +1 (866) 713-8562 in the United States and +1 (617) 597-5310 outside of the United States, passcode 19353013. The press release will be posted to the company web site http://www.xyratex.com.

A replay will be available through January 13, 2009 following the live call by dialing +1 (888) 286-8010 in the United States and +1 (617) 801-6888 outside the United States, replay code 81888650.

(1) Non-GAAP net income (loss) and diluted earnings (loss) per share excludes (a) amortization of intangible assets, (b) equity compensation expense, (c) specified non-recurring or non-cash items, such as the impairment of goodwill and the valuation allowance against a deferred tax asset, and (d) the related tax effects. Reconciliation of non-GAAP net income and diluted earnings per share to GAAP net income and GAAP diluted earnings per share is included in a table immediately following the condensed consolidated statements of cash flow below.

The intention in providing these non-GAAP measures is to provide supplemental information regarding the Company's operational performance whilst recognizing that they have material limitations and that they should only be referred to with reference to the corresponding GAAP measure.

The Company believes that the provision of these non-GAAP financial measures is useful to investors and investment analysts because it enables comparison to the Company's historical operating results, those of competitors and other industry participants and also provides transparency to the measures used by management in operational and financial decision making. In relation to the specific items excluded: (a) intangible assets represent costs incurred by the acquired business prior to acquisition, are not cash costs and will not be replaced when the assets are fully amortized and therefore the exclusion of these costs provides management and investors with better visibility of the costs required to generate revenue over time; (b) equity compensation expense is non-cash in nature, is outside the control of management during the period in which the expense is incurred and in addition has not been measured consistently as a result of the implementation of FAS 123R; (c) the impairment of goodwill and the valuation allowance against the deferred tax asset is non-recurring, non-cash and is not comparable across periods or with other companies; (d) the exclusion of the related tax effects of excluding items (a) to (c) is necessary to show the effect on net income of the change in tax expense that would have been recorded if these items had not been incurred.

Safe Harbor Statement

This press release contains forward-looking statements. These statements relate to future events or our future financial performance. These statements are only predictions and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to differ materially from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Factors that might cause such a difference include our inability to compete successfully in the competitive and rapidly changing marketplace in which we operate, failure to retain key employees, changes in our customers volume requirements, cancellation or delay of projects and adverse general economic conditions in the United States and internationally. These risks and other factors include those listed under "Risk Factors" and elsewhere in our Annual Report on Form 20-F as filed with the Securities and Exchange Commission (File No. 000-50799). In some cases, you can identify forward-looking statements by terminology such as "may," "will," "should," "expects," "intends," "plans," "anticipates," "believes," "estimates," "predicts," "potential," "continue," or the negative of these terms or other comparable terminology. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements.

About Xyratex

Xyratex is a leading provider of enterprise class data storage subsystems and storage process technology. The company designs and manufactures enabling technology that provides OEM and disk drive manufacturers with data storage products to support high-performance storage and data communication networks. Xyratex has over 20 years of experience in research and development relating to disk drives, storage systems and high-speed communication protocols.

Founded in 1994 in an MBO from IBM, and with headquarters in the UK, Xyratex has an established global base with R&D and operational facilities in Europe, the United States and South East Asia. For more information, visit http://www.xyratex.com.





                                 XYRATEX LTD
    PRELIMINARY UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

                                      Three Months Ended,     Year Ended
                                      November  November  November   November
                                         30,       30,       30,        30,
                                        2008      2007      2008       2007
                                      (US dollars in thousands, except per
                                                  share amounts)

    Revenues:
      Networked Storage Solutions     $222,300  $187,216   $855,770  $693,990
      Storage Infrastructure            63,127    60,772    193,946   237,643
    Total revenues                     285,427   247,988  1,049,716   931,633

    Cost of revenues                   257,327   202,133    898,639   762,582
    Gross profit:
      Networked Storage Solutions       11,143    28,165     99,775   100,573
      Storage Infrastructure            17,234    18,046     52,566    69,716
      Equity compensation                 (277)     (356)    (1,264)   (1,238)
    Total gross profit                  28,100    45,855    151,077   169,051
    Operating expenses:
       Research and development         22,726    19,370     85,897    77,559
       Selling, general and
        administrative                  15,984    16,532     63,686    61,977
       Amortization of intangible
        assets                           1,223     2,485      4,882     7,304
       Impairment of goodwill           34,256         -     34,256         -
        Total operating expenses        74,189    38,387    188,721   146,840
    Operating income (loss)            (46,089)    7,468    (37,644)   22,211
    Other income                             -         -          -       890
    Interest income, net                   166     1,030      1,618     3,283
    Income (loss) before income taxes  (45,923)    8,498    (36,026)   26,384
    Provision (benefit) for income
     taxes                              17,324    (3,229)    19,383    (1,725)
    Net income (loss)                 $(63,247)  $11,727   $(55,409)  $28,109

    Net earnings (loss) per share:
      Basic                             $(2.17)    $0.40     $(1.90)    $0.97
      Diluted                           $(2.17)    $0.39     $(1.90)    $0.94

    Weighted average common shares
     (in thousands), used in
     computing net earnings (loss)
     per share:
      Basic                             29,096    29,100     29,157    28,985
      Diluted                           29,096    29,758     29,157    29,866



                                 XYRATEX LTD
         PRELIMINARY UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS

                                                 November 30,     November 30,
                                                    2008              2007
                                         (US dollars and amounts in thousands)

    ASSETS
    Current assets:
      Cash and cash equivalents                    $28,013           $70,678
      Accounts receivable, net                     140,879           122,327
      Inventories                                  123,783            91,662
      Prepaid expenses                               2,746             2,994
      Deferred income taxes                          1,000             3,000
      Other current assets                           4,430             8,275
        Total current assets                       300,851           298,936
      Property, plant and equipment, net            47,229            37,421
      Intangible assets, net                        11,195            54,175
      Deferred income taxes                          9,545            19,743
        Total assets                              $368,820          $410,275

    LIABILITIES AND SHAREHOLDERS' EQUITY
    Current liabilities:
      Accounts payable                            $111,295           $96,046
      Employee compensation and benefits
       payable                                       9,745            13,280
      Deferred revenue                               8,386            15,212
      Income taxes payable                           2,573             1,165
      Other accrued liabilities                     30,732            11,311
        Total current liabilities                  162,731           137,014
      Long-term debt                                   -                 -
        Total liabilities                          162,731           137,014

    Shareholders' equity
      Common shares of Xyratex Ltd (in
       thousands), par value $0.01 per
       share 70,000 authorized, 29,146 and
       29,117 issued and outstanding                   293               291
      Additional paid-in capital                   366,065           356,268
      Accumulated other comprehensive
       income                                      (13,603)            1,847
      Accumulated deficit                         (146,666)          (85,145)
        Total shareholders' equity                 206,089           273,261
        Total liabilities and
         shareholders' equity                     $368,820          $410,275



                                 XYRATEX LTD
    PRELIMINARY UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

                                                          Year Ended
                                                 November 30,     November 30,
                                                     2008             2007
                                                   (US dollars in thousands)
    Cash flows from operating activities:
    Net income (loss)                              $(55,409)          $28,109
    Adjustments to reconcile net income
     (loss) to net cash
      provided by operating activities:
    Depreciation                                     15,770            13,683
    Amortization of intangible assets                 4,882             7,304
    Impairment of intangible assets                  34,256               -
    Non-cash equity compensation                      7,646             8,057
    Loss on sale of assets                              185               341
    Changes in assets and liabilities,
     net of impact of acquisitions and
     divestitures
      Accounts receivable                           (18,552)          (17,003)
      Inventories                                   (32,121)            1,449
      Prepaid expenses and other current
       assets                                         1,455            (2,956)
      Accounts payable                               15,249            11,150
      Employee compensation and benefits
       payable                                       (3,535)           (3,365)
      Deferred revenue                               (6,826)           (1,091)
      Income taxes payable                            1,408              (476)
      Deferred income taxes                          16,944            (1,616)
      Other accrued liabilities                       5,818            (2,266)
        Net cash provided by (used in)
         operating activities                       (12,830)           41,320

    Cash flows from investing activities:
      Investments in property, plant and
       equipment                                    (25,763)          (16,974)
      Acquisition of intangible assets                  -              (4,833)
      Acquisition of business, net of
       cash received                                    -              (1,661)
        Net cash used in investing
         activities                                 (25,763)          (23,468)

    Cash flows from financing activities:
      Payments of long-term borrowings                  -              (7,000)
      Repurchases of common shares                   (6,116)              -
      Proceeds from issuance of shares                2,044             2,905
        Net cash used in financing
         activities                                  (4,072)           (4,095)
    Change in cash and cash equivalents             (42,665)           13,757
    Cash and cash equivalents at
     beginning of period                             70,678            56,921
    Cash and cash equivalents at end of
     period                                         $28,013           $70,678



                                 XYRATEX LTD
                     PRELIMINARY SUPPLEMENTAL INFORMATION

                                        Three Months Ended     Year Ended
                                        November  November  November  November
                                           30,       30,      30,       30,
    Summary Reconciliation Of GAAP Net
     Income To Non-GAAP Net Income         2008     2007      2008     2007
                                        (US dollars in      (US dollars in
                                        thousands, except   thousands, except
                                        per share amounts)  per share amounts)

    GAAP net income (loss)              ($63,247) $11,727   ($55,409) $28,109

      Amortization of intangible assets    1,223    2,485      4,882    7,304
      Impairment of goodwill              34,256        -     34,256        -
      Equity compensation                  1,755    2,237      7,646    8,057
      Other income                             -        -          -     (890)
      Tax effect of non-GAAP adjustments  (1,024)  (1,602)    (3,791)  (4,050)
      Valuation allowance against UK
       deferred tax asset                 20,632        -     20,632        -
      Effect on deferred tax of changes
       to UK tax rates and exchange
       rates                                 110   (1,743)     1,254   (1,040)

    Non-GAAP net income                  ($6,295) $13,104     $9,470  $37,490


    Summary Reconciliation Of Diluted
     GAAP Earnings Per Share To Diluted
     Non-GAAP Earnings Per Share

    Diluted GAAP earnings (loss) per
     share                                ($2.17)   $0.39     ($1.90)   $0.94

      Amortization of intangible assets    $0.04    $0.08      $0.17    $0.24
      Impairment of goodwill               $1.18    $0.00      $1.17    $0.00
      Equity compensation                  $0.06    $0.08      $0.26    $0.27
      Other income                         $0.00    $0.00      $0.00   ($0.03)
      Tax effect of non-GAAP adjustments  ($0.03)  ($0.05)    ($0.13)  ($0.14)
      Valuation allowance against UK
       deferred tax asset                  $0.71    $0.00      $0.71    $0.00
      Effect on deferred tax of changes
       to UK tax rates and exchange
       rates                               $0.00   ($0.06)     $0.04   ($0.03)

    Diluted non-GAAP earnings per share   ($0.22)   $0.44      $0.32    $1.26


    Summary Of Equity Compensation

      Cost of revenues                       277      356      1,264    1,238
      Research and development               567      711      2,469    2,477
      Selling, general and
       administrative                        911    1,170      3,913    4,342

      Total equity compensation            1,755    2,237      7,646    8,057

SOURCE Xyratex Ltd